Cart (0 Items)
Your cart is currently empty.
View ProductsClivatuzumab Biosimilar – Anti-MUC1, CD227 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Clivatuzumab Biosimilar - Anti-MUC1, CD227 mAb - Research Grade |
|---|---|
| Source | CAS 1462876-11-4 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Clivatuzumab,hPAM4,hPAM4 IgG-DOTA,hPAM4-DOTA,MUC1, CD227,anti-MUC1, CD227 |
| Reference | PX-TA1390 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Clivatuzumab Biosimilar - Anti-MUC1, CD227 mAb - Research Grade
General information on Anti-MUC1/CD227[Homo sapiens] (Clivatuzumab) Monoclonal Antibody
Clivatuzumab is investigated for the treatment of Pancreatic Cancer.
Related products
Antigen
Cell surface glycoprotein MUC18(MCAM)
PX-P4862 210€
Antigen
MUC16 recombinant protein
PX-P5181 420€
Antigen
Human MUC17 recombinant protein
PX-P6035 385€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.